Clinical Trials Browser

Active not recruiting × Recurrence × Gemcitabine × Clear all

NCT04984837 2026-06-04

Study of Lacutamab in Peripheral T-cell Lymphoma

Phase 2 Active not recruiting

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT05294172 2026-05-08

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Phase 3 Active not recruiting

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT04442022 2026-05-06

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase 2/3 Active not recruiting

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02151084 2025-12-16

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer

Phase 2 Active not recruiting

Gastrointestinal

Gallbladder Neoplasms, Recurrence

NCT02202772 2025-02-24

CGC

Phase 1/2 Active not recruiting

Carcinoma, Neoplasms, Recurrence

NCT02203760 2024-11-15

PazoDoble

Phase 2 Active not recruiting

Carcinosarcoma, Leiomyosarcoma, Recurrence